Correction to Covid-19 Antibody Drugs Article
October 09 2020 - 11:09AM
Dow Jones News
Regeneron Pharmaceuticals has produced enough supply of its
antibody drug to treat 50,000 patients. "Antibody Drugs Touted by
Trump Could Be Next to Get Authorized for Covid-19" at 5:30 a.m.
ET, incorrectly said it has enough supply to treat 30,000
patients.
(END) Dow Jones Newswires
October 09, 2020 10:54 ET (14:54 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Sep 2023 to Sep 2024